2-May-2024
No headlines found.
Globe Newswire (Tue, 9-Apr 7:30 AM ET)
Globe Newswire (Thu, 28-Mar 4:05 PM ET)
Globe Newswire (Thu, 28-Mar 7:30 AM ET)
Globe Newswire (Thu, 15-Feb 8:00 AM ET)
Globe Newswire (Tue, 6-Feb 7:30 AM ET)
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an advanced therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by our company and prescribed by specially trained dentists in cooperation with their medical colleagues.
Vivos Therapeutics trades on the NASDAQ stock market under the symbol VVOS.
As of May 2, 2024, VVOS stock price climbed to $2.63 with 23,014 million shares trading.
VVOS has a beta of 1.48, meaning it tends to be more sensitive to market movements. VVOS has a correlation of 0.01 to the broad based SPY ETF.
VVOS has a market cap of $7.84 million. This is considered a Sub-Micro Cap stock.
Last quarter Vivos Therapeutics reported $3 million in Revenue and -$3.05 earnings per share. This fell short of revenue expectation by $-162,000 and missed earnings estimates by -$1.15.
In the last 3 years, VVOS stock traded as high as $178.05 and as low as $2.37.
The top ETF exchange traded funds that VVOS belongs to (by Net Assets): VXF.
VVOS has underperformed the market in the last year with a price return of -69.6% while the SPY ETF gained +23.2%. VVOS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -57.2% and -1.1%, respectively, while the SPY returned +3.6% and +0.9%, respectively.
VVOS support price is $2.35 and resistance is $2.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VVOS stock will trade within this expected range on the day.